title: Adalimumab in the treatment of recurrent idiopathic bilateral nodular scleritis.
abstract: Our objective is to report a case of bilateral nodular scleritis in a 34-year-old patient, resistant to steroids and traditional disease modifying anti-rheumatic drugs, who was successfully treated with subcutaneous injections of 40 mg adalimumab. Adalimumab resulted in rapid control of scleritis in both eyes within 3 months with no recurrence over 5 years of follow-up. No side effects were reported during treatment.Although a large prospective study and a longer follow-up are required to reach a conclusive result, adalimumab has a potential role in the treatment of the above condition with the control of inflammation.
authors.affiliation: Department of Ophthalmology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
authors.forename: Ahmed M
authors.initials: AM
authors.lastname: Bawazeer
authors.forename: Lina H
authors.initials: LH
authors.lastname: Raffa